ArticleCommunications medicine2022

Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes.

Shu Ning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.